{"disease":{"id":"targeted-molecular-therapy","name":"targeted molecular therapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06218901","title":"Association of Psychological Distress in Patients With Lung Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT05177666","title":"a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"The University of Hong Kong-Shenzhen Hospital","has_results":false},{"nct_id":"NCT04720131","title":"Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}